LGND · Ligand Pharmaceuticals Inc · Congressional Trades
$302.74
-9.63 (-3.08%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$6.01B
Shares
19.94M
Volume · Oct 1
430.95K
Avg daily vol (3M)
274.83K
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
| Date | Member | Position | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Gilbert Cisneros | Representative | Buy ST · Ligand Pharmaceuticals Incorporated - Common Stock (LGND) | — 150 Main Street Trust > Bank of America | $1K - $15K | 2026-06-08 | 10d |
| 2026-03-03 | Gilbert Cisneros | Representative | Buy ST · Ligand Pharmaceuticals Incorporated - Common Stock (LGND) | — 150 Main Street Trust > Bank of America | $1K - $15K | 2026-04-07 | 35d |
| 2026-01-15 | Gilbert Cisneros | Representative | Buy ST · Ligand Pharmaceuticals Incorporated - Common Stock (LGND) | — 150 Main Street Trust > Bank of America | $1K - $15K | 2026-02-13 | 29d |
| 2026-01-05 | Gilbert Cisneros | Representative | Buy ST · Ligand Pharmaceuticals Incorporated - Common Stock (LGND) | — 150 Main Street Trust > Bank of America | $1K - $15K | 2026-02-13 | 39d |
| 2020-10-22 | Katherine M. Clark | Representative | Sell ST · ligand Pharmaceuticals Incorporated (lgNd) | SP Ameriprise Traditional IRA | $1K - $15K | 2020-12-03 | 42d |
| 2020-10-22 | Katherine M. Clark | Representative | Sell ST · ligand Pharmaceuticals Incorporated (lgNd) | SP Ameriprise SEP IRA | $1K - $15K | 2020-12-03 | 42d |
| 2020-04-03 | Katherine M. Clark | Representative | Buy ST · ligand Pharmaceuticals Incorporated (lgNd) | SP Ameriprise Traditional IRA | $1K - $15K | 2020-05-29 | 56d late |
| 2020-04-03 | Katherine M. Clark | Representative | Buy ST · ligand Pharmaceuticals Incorporated (lgNd) | SP Ameriprise SEP IRA | $1K - $15K | 2020-05-29 | 56d late |
Showing 1–8 of 8 trades
Key facts
CIK
886163
CUSIP
53220K504
13F (30d)
14 filings
11 filers
Visit website
Investor relations